Zheng-fan Jiang
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
CTLA-4 polymorphisms are associated with treatment outcomes of patients with multiple myeloma receiving bortezomib-based regimens.
Journal: Annals of hematology
Published: April 17, 2017
Erratum to "Increased Type 1 Immune Response in the Bone Marrow Immune Microenvironment of Patients with Poor Graft Function after Allogeneic Hematopoietic Stem Cell Transplantation" [Biol Blood Marrow Transplant 2016;22:1376-1382].
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
Published: October 12, 2016
Recipient-donor KIR ligand matching prevents CMV reactivation post-haploidentical T cell-replete transplantation.
Journal: British journal of haematology
Published: August 15, 2016
Increased Type 1 Immune Response in the Bone Marrow Immune Microenvironment of Patients with Poor Graft Function after Allogeneic Hematopoietic Stem Cell Transplantation.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
Published: December 15, 2015
Poor CMV-specific CD8+ T central memory subset recovery at early stage post-HSCT associates with refractory and recurrent CMV reactivation.
Journal: The Journal of infection
Published: November 08, 2015
Rat and human STINGs profile similarly towards anticancer/antiviral compounds.
Journal: Scientific reports
Published: September 17, 2015
The structural basis for the sensing and binding of cyclic di-GMP by STING.
Journal: Nature structural & molecular biology
Published: April 11, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026